Aerovate Therapeutics, Inc. (AVTE) Misses Q1 EPS by 10c
Tweet
Share
E-mailGet Alerts AVTE Hot Sheet
Join SI Premium – FREE
Aerovate Therapeutics, Inc. (NASDAQ: AVTE) reported Q1 EPS of ($0.67), $0.10 worse than the analyst estimate of ($0.57).
For earnings history and earnings-related data on Aerovate Therapeutics, Inc. (AVTE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla to launch Cybercab in Austin this month - report
- XP Inc. (XP) Tops Q2 EPS by 8c
- H.C. Wainwright Reiterates Buy Rating on Jasper Therapeutics (JSPR)
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
